 | • レポートコード：MRC2303I0080 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥688,750 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,268,750 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の歯科用骨移植代替物市場規模が、予測期間中（2022年〜2027年）に年平均6.8%で成長すると予測しています。本レポートは、歯科用骨移植代替物の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（異種移植、同種移植、自家移植、その他）分析、メカニズム別（骨伝導、骨誘導、骨形成）分析、エンドユーザー別（病院、歯科医院、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などを以下の構成でまとめています。また、Dentsply Sirona、Johnson & Johnson、Institut Straumann AG、Medtronic PLC、ZIMMER BIOMET、Geistlich Pharm、Dentium、LifeNet Health、Collagen Matrix Inc.、Halma plc (Novabone LLC)、Botiss biomaterials GmbH、Wright Medical Group NVなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の歯科用骨移植代替物市場規模：種類別 - 異種移植の市場規模 - 同種移植の市場規模 - 自家移植の市場規模 - その他種類の市場規模 ・世界の歯科用骨移植代替物市場規模：メカニズム別 - 骨伝導の市場規模 - 骨誘導の市場規模 - 骨形成の市場規模 ・世界の歯科用骨移植代替物市場規模：エンドユーザー別 - 病院における市場規模 - 歯科医院における市場規模 - その他エンドユーザーにおける市場規模 ・世界の歯科用骨移植代替物市場規模：地域別 - 北米の歯科用骨移植代替物市場規模 アメリカの歯科用骨移植代替物市場規模 カナダの歯科用骨移植代替物市場規模 メキシコの歯科用骨移植代替物市場規模 … - ヨーロッパの歯科用骨移植代替物市場規模 ドイツの歯科用骨移植代替物市場規模 イギリスの歯科用骨移植代替物市場規模 フランスの歯科用骨移植代替物市場規模 … - アジア太平洋の歯科用骨移植代替物市場規模 中国の歯科用骨移植代替物市場規模 日本の歯科用骨移植代替物市場規模 インドの歯科用骨移植代替物市場規模 … - 中東/南米の歯科用骨移植代替物市場規模 南アフリカの歯科用骨移植代替物市場規模 ブラジルの歯科用骨移植代替物市場規模 アルゼンチンの歯科用骨移植代替物市場規模 … - その他地域の歯科用骨移植代替物市場規模 ・競争状況 ・市場機会・将来の動向 |
The dental bone graft substitutes market is expected to witness a CAGR of 6.8% over the forecast period, 2022-2027.
The COVID-19 pandemic has impacted industries worldwide. As all healthcare providers were engaged with COVID-19 management, access was restricted to essential care only, and the temporary closure of dental clinics drastically reduced dental surgeries. For instance, the American Dental Association (ADA) recommended that elective dental procedures be postponed until April 6, 2020, and dental practices should provide emergency-only dental services. Additionally, as per April 1, 2020, update, the ADA advised offices to remain closed to all but urgent and emergency procedures until April 30, at the earliest, owing to increasing COVID-19 cases. As a result, access to dental care was substantially decreased. Moreover, in March 2020, an ADA health policy institute survey indicated that 76% of dental offices surveyed were closed but seeing emergency patients only, 19% were completely closed, and 5% were open but seeing a lower volume of patients. These factors severely impacted dental bone graft substitute manufacturers and their supply chains. Thus, these statistics indicate that the demand for dental bone graft substitutes was reduced during the COVID-19 pandemic.
Furthermore, the significant factors responsible for the market’s growth include the rising demand for medical and dental tourism; the increasing burden of dental diseases; and technological advancements in dentistry. The rising burden of dental diseases is driving the market’s growth. For instance, according to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffer from caries of their primary teeth.
To maintain the existing jaw, bone grafting is done before implant placement, which helps with successful implant surgery. Thus, increasing the use of such synthetic and biocompatible grafts in dental procedures ultimately triggers the market’s growth. As per a May 2020 published study titled “Global Prevalence of Periodontal Disease and Lack of Its Surveillance,” periodontitis was most common in older people and populations from high-income countries. The distribution varied significantly between low-income (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income (43.7%) countries. Additionally, according to the International Dental Journal’s article titled, “Risk Indicators of Tooth Loss among the Mexican Adult Population: A Cross-Sectional Study,” published in February 2021, tooth loss was 57.2% due to tooth decay in Mexico. Hence, owing to the aforementioned factors, the market is expected to witness significant growth in the future.
Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in April 2022, the Aspen Group and ACE Surgical Supply, one of the providers of bone regenerative products, signed a multi-year strategic partnership for dental bone grafting solutions.
Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, expensive dental procedures and reimbursement issues hinder the market’s growth.
Dental Bone Graft Substitutes Market Trends
The Xenogaft Segment is Expected to Grow Over the Forecast Period
The xenograft segment is expected to hold a significant market share by type. A xenograft is an organ transplant or a tissue graft to an individual of another species. Xenografts are obtained from pigs (porcine) or cows (bovine) and are prepared for implantation into the human body once thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in dentistry. A few commercially available xenografts are Bio-Oss, Bio-Oss Collagen, and Pepgen-P15, among others. As xenograft are most affordable, the key players in the market are taking initiatives to launch new products.
For instance, in March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organisation (CDSCO), India. With this, the company aims to penetrate the dental fraternity across India. Such developments are expected to fuel the development of dental bone graft substitutes for xenografts, thereby boosting the segment’s growth.
Additionally, the strategic initiatives taken by the market players are also contributing to the growth of the market. For instance, in September 2021, Neoss signed an agreement with Purgo Biologics and became a key partner and distributor of the Purgo Xenograft product range for dental implant solutions in the German, Swedish, and United Kingdom markets.
Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the global dental bone graft substitutes market. The United States is likely to hold a significant market share in the North American region. The major factors contributing to the market’s growth are strategic initiatives undertaken by the market players and the growing number of dental visits.
For instance, according to the Centers for Disease Control and Prevention (CDC) data updated in January 2021, 1 in 4 adults between 20-64 years of age suffer from at least one cavity, and almost 57% of adolescents aged 12-19 have had a hole in their permanent teeth. Also, as per December 2020 statistics by the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults have untreated tooth decay, and nearly half (46%) of all adults aged 30 years or older show signs of gum disease; and severe gum disease affects about 9% of adults in the United States. These statistics indicate that the percentage of the population visiting dental clinics for examinations contributes to the market’s growth.
Moreover, the growing number of strategic initiatives such as product launches, approvals, acquisitions, mergers, partnerships, and joint ventures are anticipated to boost regional growth. For instance, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products, in January 2021. With this acquisition, Dentsply Sirona promotes the complete OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in the United States, Canada, and several other countries.
Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.
Dental Bone Graft Substitutes Market Competitor Analysis
The dental bone graft substitutes market is highly competitive, with several players worldwide. In terms of market share, few significant players currently dominate the market. With the rising patient awareness levels and high prevalence of dental disorders, many regional players are expected to be part of the dental bone graft substitute market over the forecast period. Some of the market’s major players are Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET, etc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand of Medical and Dental Tourism
4.2.2 Rising Burden of Dental Diseases
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Expensive Dental Procedures
4.3.2 Reimbursement Issues
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Xenograft
5.1.2 Allograft
5.1.3 Autograft
5.1.4 Other Types
5.2 By Mechanism
5.2.1 Osteoconduction
5.2.2 Osteoinduction
5.2.3 Osteogenesis
5.2.4 Osteopromotion
5.3 By End Users
5.3.1 Hospitals
5.3.2 Dental Clinics
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Dentsply Sirona
6.1.2 Johnson & Johnson
6.1.3 Institut Straumann AG
6.1.4 Medtronic PLC
6.1.5 ZIMMER BIOMET
6.1.6 Geistlich Pharm
6.1.7 Dentium
6.1.8 LifeNet Health
6.1.9 Collagen Matrix Inc.
6.1.10 Halma plc (Novabone LLC)
6.1.11 Botiss biomaterials GmbH
6.1.12 Wright Medical Group NV
7 MARKET OPPORTUNITIES AND FUTURE TRENDS